David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 2,291 shares at $2.08 ($5K) on 2016-02-19, disclosed to the SEC on 2016-02-23.
Scheduled purchase ($5k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 1,700 | $4K | 74.1% |
| 2 | $2.09 | 591 | $1K | 25.9% |
| Total | $2.08 avg | 2,291 | $5K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |